+
Site Tour
NAVITOR™
TAVI SYSTEM
TAVI

Stable delivery. Remarkable performance. Future ready.

LEARN HOW EXCELLENT JUST GOT BETTER



REMARKABLE PERFORMANCE.
STABLE DELIVERY.
FUTURE READY.
 

DISCOVER WHAT HEART VALVE TREATMENT EXPERTS THINK

REMARKABLE PERFORMANCE

Now you've got Navitor. Remarkable performance.

L. Testa

"This active cuff is really able to do what it promises"

STABLE DELIVERY

Now you've got Navitor.
Stable delivery.

N. Van Mieghen

"Navitor™ is a device iteration that  really has changed  the way we do our implantation"

FUTURE READY

Now you've got Navitor.
Future ready.

R. Dworakowski

"It's an ideal valve to be used for patients who may require future coronary interventions"

REMARKABLE PERFORMANCE

Now you've got Navitor. Remarkable performance.

L. Testa

"This active cuff is really able to do what it promises"

STABLE DELIVERY

FUTURE READY

Now you've got Navitor.
Future ready.

R. Dworakowski

"It's an ideal valve to be used for patients who may require future coronary interventions"

WATCH ON-DEMAND:

ESC 2025 VANTAGE STUDY  TAVI Webinars 2025  TAVI SUMMIT 2025  TAVI SUMMIT 2024   EURO PCR 2024

Connext
Hub

Learn emerging and established information on cardiovascular conditions and stroke prevention technologies.

Find out more

TV

VANTAGE study roundtable on clinical outcomes

Expanding TAVI to Low- And Intermediate-Risk Patients

D. Wykrzykowska, N. Van Mieghem, G. Tarantini

VANTAGE study insights by M. Adamo

Lifetime Management in Low- And Intermediate-Risk TAVI: Insights on Navitor and the VANTAGE Data

M. Adamo

VANTAGE study insights by B. Gonska

Lifetime Management in Low- And Intermediate-Risk TAVI: Insights on Navitor and the VANTAGE Data

B. Gonska

VANTAGE study insights by N. Van Mieghem

Lifetime Management in Low- And Intermediate-Risk TAVI: Insights on Navitor and the VANTAGE Data

N. Van Mieghem

TAVI Summit 2025 - Welcome & meeting objectives

Welcome & meeting objectives

M. Akodad, N. Piazza

TAVI Summit 2025 - Beyond the TAVI implant

Beyond the TAVI implant: a strategic approach to lifetime management

N. Piazza, A. Öner

TAVI Summit 2025 - Selecting the right index valve

Key factors in selecting the right index valve

D. Dvir

TAVI Summit 2025 - Understanding advancing the implant technique

Lessons learned: advancing the implant technique

R. Dworakowski

TAVI Summit 2025 - Ensuring future TAVI success

Ensuring future TAVI success: planning for re-do procedures

O. Angeras

TAVI Summit 2025 - Reducing PPI rate

What are key factors towards reducing PPI rates?

N. Piazza

© Abbott 2025. All rights reserved. 9-EH-5-14383-01 10-2025 REV F

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline